Cargando…
LIMK2 Is a Novel Prognostic Biomarker and Correlates With Tumor Immune Cell Infiltration in Lung Squamous Cell Carcinoma
Previous research found that LIM domain kinase 2 (LIMK2) expression correlated with a poor prognosis in many cancers. However, its role in lung squamous cell carcinoma (LUSC) has not yet been clarified. Our study aimed to clarify the role of LIMK2 in LUSC prognosis prediction and explore the relatio...
Autores principales: | Su, Yongcheng, Xu, Beibei, Shen, Qianwen, Lei, Ziyu, Zhang, Wenqing, Hu, Tianhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902256/ https://www.ncbi.nlm.nih.gov/pubmed/35273591 http://dx.doi.org/10.3389/fimmu.2022.788375 |
Ejemplares similares
-
Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer
por: Su, Yongcheng, et al.
Publicado: (2023) -
LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancer
por: Liu, Xin, et al.
Publicado: (2022) -
Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021) -
OIP5 Is a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates
por: Gong, Mancheng, et al.
Publicado: (2022) -
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers
por: Pan, Jing-hua, et al.
Publicado: (2019)